The RCVS is seeking candidates to run for election to the RCVS and VN Councils.
There are six seats on the RCVS Council and two on the VN Council due to be filled in the 2010 election. Candidate nominations must be received by 31 January 2010; voting papers will then be distributed to all veterinary surgeons and veterinary nurses eligible to vote, the election held in March and the results announced early in May. Those elected will take their seats at RCVS Day in July to serve four-year terms.
Jane Hern, RCVS Registrar said: "Like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients. Getting regulation right is something that all Members and Listed/Registered VNs have power to influence.
"We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards," Jane continued. "There has been a substantial rise in the number of vets voting, since a low point in voter turnout was reached in 2002. So, if you know someone you think is up to the job, why not persuade them to stand?"
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, 'manifesto' and photograph for inclusion in the elections booklets. Nobody can nominate more than one candidate, and no current member of the RCVS Council or VN Council may nominate anyone.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members are permitted to claim certain expenditures arising from Council-related duties and their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk/rcvscouncil10 or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council will be online shortly at www.rcvs.org.uk/vncouncil10 and can also be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk).
All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
Genitrix has launched Dentagen toothpaste which, the company says, uniquely both cleans teeth and inhibits the formation of plaque.
Dentagen toothpaste is based on RF2, a plant extract, which is clinically proven to inhibit the formation of dental biofilm or plaque. It has been formulated to a dentrifrice abrasivity (RDA) index of 34 to ensure that it removes plaque while causing no damage to the enamel layer of the teeth. The toothpaste is packaged with a free finger-brush to help introduce the pet to having its teeth brushed. It costs £5.50 for a 70g tube.
The toothpaste completes the range of Dentagen health products - the fastest growing dental products in the UK (according to GFK data in May 2010).
Genitrix says Dentagen is the only veterinary dental system to combine a procedure carried out in practice with a variety of aftercare regimes to ensure owner compliance. In 2008, Genitrix launched the Dentagen plaque protection system. It consists of a RF2-impregnated wax provided to practices in a syringe and applied to the gingival layer and the buccal area of teeth of dogs or cats at the end of dental procedures. Pet owners then maintain the protective coating by using the new Dentagen toothpaste or other products in the range - either the RF2-impregnated vegetable-based palatable Dentagen chews or Dentagen Aqua, a palatable liquid containing RF2, which is added to a pet's drinking water on a daily basis.
Rob Watkins, Genitrix' Marketing Director, said: "Brushing has long been recognised as the 'gold standard' when it comes to dental health care so we felt it was important for the Dentagen range to include this option. Regular brushing makes a significant contribution to the maintenance of oral health and the RF2 in the Dentagen toothpaste actually suppresses plaque formation between brushing which is a further benefit. It sets a new efficacy standard for pet toothpaste.
However, while many owners understand the importance of dental health, many of them find actually brushing their pet's teeth difficult - especially those with cats. This is why the Dentagen range includes a variety of options. It enables pet owners to select the method that is right for them and their pet and thus maximise the likelihood of their compliance with a good preventive health regime."
Biobest is highlighting the benefits of using its canine prostate specific arginine esterase (CPSE) test to differentiate between those dogs which have benign prostatic hyperplasia and those suffering more serious conditions, such as neoplasia.
Benign prostatic hyperplasia is a common condition of entire dogs with over 50% of dogs over 5 years of showing histological evidence of BPH.
Paul Burr MRCVS from Biobest said: "While the clinical stages of prostatic disease are not difficult to diagnose, differentiating BPH from other causes of prostatic disease such as prostatic cysts, prostatitis, prostatic abscesses or neoplasia is less simple. Traditionally further investigation would include bacteriology and cytology on a prostatic wash or final needle aspirate, and prostatic ultrasonography."
Although the CPSE test has been available for a couple of years now, Paul says the benefits of the test have not thus far been well-explained: "I think most vets probably think it's just a test for Prostatic Disease, something which is easy enough to diagnose without testing.
"While the test can be used as part of an annual check up to look for pre-clinical BPH in entire male dogs, it's real value is that it is a simple, convenient non-invasive blood test that helps determine whether a dog presenting with signs of prostatic disease is most likely to be suffering from BPH or a more serious condition that requires further investigation."
For more information about the CPSE test, contact Biobest on 0131 440 2628 or email enquiry@biobest.co.uk.
The company points to research which showed that in the US, and despite the importance of annual health checks, 45.7% of cats did not visit a veterinary surgeon in the year the study was conducted. Of those, 41% cited the reason as their “cats did not get sick or injured.” Only 16% said they did not have the money to pay for a veterinary visit.1,2
Apparently, a more recent poll by International Cat Care (ICC) also found that 50% of cat owners struggle to get their cat into a carrier, which is obviously a barrier to taking their pet to the veterinary clinic.
To help more cats get to the vet, International Cat Care has developed educational materials and a range of training aids including free online training videos, podcasts, emails and giveaways. They're available at: https://icatcare.org/international-cat-day.
Dr. Michael McFarland, Chief Medical Officer at Zoetis, said: "Many cat owners find it incredibly difficult and stressful getting cats into a carrier. As a result, many are reluctant to take their cat to their veterinarian unless they have a major health issue.
“Cats are intelligent animals and we want owners to know that they respond well to training. The ICC survey found that owners who use positive training and rewards find it much easier to get their cats into a carrier, so we are delighted to support the #BeCatCurious campaign this year.
“Visits to the veterinarian and giving medicines when needed are essential if we want to keep our pets healthy and protected, for example against parasites. So, encouraging owners to be more curious and to learn something new with their cat can not only strengthen the bond between them but also make life easier and healthier for cats and their owners.
References
Ki-67 is a proliferation marker used for assessing tumour aggressiveness, however the traditional method of assessing Ki-67 scores involves manually counting the proliferating cells, which is subjective, time-consuming and prone to variability.
Finn says its new AI-assisted Ki-67 scoring test represents a significant advancement in veterinary diagnostic oncopathology.
The AI algorithm analyses Ki-67 labelling across the entire section of tumour.
Positively labelled cells are highlighted, scores are calculated, and the results are validated by a pathologist before reporting.
This more automated analysis enables the evaluation of large volumes of histological data, ensuring consistent and reliable prognostic assessments.
Finn says it also removes the subjectivity and variability associated with identifying areas of highest cell proliferation, which is a crucial aspect of tumour scoring.
https://www.finnpathologists.com
To celebrate the launch of its brand new keep reproduction simple advertisement campaign, CEVA Animal Health is giving British Cattle Veterinary Association (BCVA) Congress delegates the chance to win an iPod by entering a special spot the sperm competition.
BCVA Congress runs from 26-28 November 2009 in Southport. Delegates just need to spot five sperm lurking in the banner-sized cartoon for CEVA's GnRH product Ovarelin®. The correct answers will be entered into a draw to win an iPod.
The company says its new ad campaign brings together a series of cartoons with a clever play on words to highlight the importance of a simple protocol for success with reproduction. You can follow this irresistibull series in the farm media throughout the autumn.
For further information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, www.ceva.uk.com
The deadline for candidate nominations for the RCVS and VN Council elections is fast approaching - so please hurry if you plan to stand.
There are six seats on the RCVS Council, and two on the VN Council, due to be filled in the 2010 election, but candidate nominations must be received by 31 January 2010.
Jane Hern, RCVS Registrar said: "Getting regulation right is something that all Members and Listed/Registered VNs have power to influence. We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards - and, like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients."
The elections will be held in March, and decided by all veterinary surgeons and veterinary nurses who use their vote. The results will be announced early in May, with those elected taking their seats at RCVS Day in July and serving four-year terms.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members' expenditures on hotels and travel are reimbursed. Their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council can be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk). All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
Origin (previously known as Westpoint) has announced that FarmVets SouthWest has joined the group, giving further geographical coverage to its veterinary practice network.
FarmVets SouthWest has practices at Ilminster and North Petherton in Somerset and Honiton in Devon.
Eoghan McAlonan, a director of the practice, said: "We are delighted to be joining Origin. The Origin group delivers the highest standards in veterinary services to UK agriculture, and we will bring our farmer friendly services to further enhance the groups activities".
In turn Origin says it plans to bring the wide benefits of group membership, including lab services, dairy consultancy and paraprofessional services, to further enhance the high level of service the vet team at Farmvets SouthWest provide to producers in Somerset and Devon.
Jon Mouncey, Managing Director of Westpoint Farmvets, said: "Working alongside our other Origin practices in the South West region, we can now offer all livestock producers our advanced services, ensuring their stock receive the very best in veterinary care. Our group offers a unique approach to integrated veterinary services and by applying the latest technology and research we ensure that animal health and welfare is optimised, delivering real value for our clients in a challenging agricultural climate."
The company says the sessions will help veterinary staff learn more about the condition - which affects up to 20% of dogs in the UK annually1 - the causes and consequences of osteoarthritis pain, the main predisposing risk factors and the impact of chronic pain on central sensitisation.
The CPD will look at what steps practices can take to mitigate animal suffering and increase long-term owner compliance and will encourage practices to look at their current osteoarthritis management strategy.
Kai Crawshaw, Brand Manager at Animalcare, said: "Canine osteoarthritis is a growing concern for UK vets – latest figures suggest that over two million dogs are suffering, based on current population figures.
"Managing these cases can be challenging, but through this lunch and learn session, we aim to support veterinary staff and help them to expand their knowledge and implement an improved approach for managing canine osteoarthritis.’
www.animalcare.co.uk/lunch-and-learn
Reference
Research published in EVE by Pearson in 2020 reported that 95% of equine vets work with “difficult” horses on at least a monthly basis, and that 81% of them had sustained at least one injury in the last 5 years.
The research also indicated that some vets overestimate their understanding of equine learning theory.
The BEVA says developing an extended understanding of how horses learn can make clinical care less stressful, and that reduced patient stress also improves workplace safety, which is important in a role that has been identified as one of the most dangerous civilian professions.
Gemma said: “Horses have limited cognitive skills and so we should try to better understand what motivates and reinforces unwanted behaviours rather than assuming the horse is being wilfully or maliciously disobedient.
“To do this we need to appreciate how horses learn.
"Better horse handling leads to happier horses, and this means happier vets and nurses and owners/clients with the ultimate knock on of better safety, better job satisfaction and better retention in the profession.”
The training sessions include:
Gemma added: “One of the biggest push backs I get from people that haven’t started to develop low stress vet care as a routine is that they haven’t got time. But those who do use it say that it saves them time and keeps them safer, this also brings obvious commercial benefit to the practice - so what’s not to like?”
https://www.beva.org.uk/elearning-redirect?redirect=/course/view.php?id=622
The Society for Practising Veterinary Surgeons (SPVS) has published its 2015 Fee Survey, which has revealed an increasing divergence between fees charged for routine and unroutine procedures in small animal practice.
SPVS says that small animal practices accounted for the largest proportion of responses to its survey, and that 75.9% of them had increased their fees during the last 12 months. When comparing a 'bundle' price comprising a kitten vaccination course, puppy vaccination course, cat spay, dog spay and consultation, the increase was 4.09%. However SPVS notes that this increase may be artificially low, as it relates to the sort of procedures that are regularly quoted and may therefore be constrained by the marketplace.
Perhaps more revealingly, whilst routine procedures such as vaccination had risen 3.3%, non routine procedures had risen by considerably more: pyometras were up 15.6%, cat dentals were up 17.5% and out-of-hours callouts were up 18.6%.
Equine fees showed an overall drop of 3.5% on the bundle price comprising initial routine examination, five-stage PPE, routine dental examination and float, a colic examination and the cost of sedation / waiting. Although many of the individual equine procedures showed a fee decrease, 79% of equine practices reported that they had increased fees over the past year. The largest decrease in equine fees was for sedating a horse and waiting while the horse was clipped or treated by an equine dental technician, with the fee charged being 12.5% less than last year and ranging from £12.50 to £93.82. Conversely, conducting an ultrasound scan of a mare for pregnancy had increased by 17.3% and ranged from £20 to £62.36.
For large animal vets, the fees are more tightly constrained by the commercial realities of farming and the range of fees quoted tends to be lower. This year, the overall price rise for the bundle of fees comprising routine calving, foot trimming, elective Caesarean and hourly rates for fertility work and herd health schemes was 4.1%. However, only 47.8% of large animal practices reported an increase in fees charged over the last twelve months. The largest increase reported was for paring the hind feet of a cow without sedation, which was up 24.4% and ranged in price from £19 to £70, while issuing a prescription to a farm animal client had decreased by 1.6% and ranged in price from 0 to £48.
Nick Stuart, SPVS president said: "We all know the industry is facing real challenges and this is reflected in the fee survey, with equine practices in particular decreasing many of their prices on last year. However the survey also shows that the fees vets charge vary widely, particularly in the small animal sector. While some of this can be accounted for by differing overheads, it does provide a fascinating insight into the various financial models that exist and challenges practice owners to review how they construct their fees. It also suggests that there is scope for practices to grow their profitability and understanding the market will help them with this.
"We have a new benchmarking service from Veterinary Insights that will help practices to set more accurate fee levels and we will be developing our fee survey further so that it dovetails with this service. I would urge practices to join SPVS and access the invaluable data we produce to help them grow their businesses."
For more information, a copy of the survey, or to join SPVS visit www.spvs.org.uk
The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.
The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).
Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.
"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.
"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."
Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.
The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.
Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
The support packs include a social media toolkit with graphics for practices to use on their own social media channels.
Visitors to the company's stand at the London Vet Show will also be able to sign up to receive a Practice Pet Protection Pack which contains a detail aid, a general microchipping leaflet, a law guides for horses, dogs and cats, and puppy and kitten leaflets.
https://identichip.co.uk
40% of Brits are more likely to trust their vet's advice above that of other health practitioners such as GPs, dentists and opticians, according to research announced today by Petplan.
The younger generation are the least trusting in their human healthcare providers with a resounding majority of those surveyed in the 16 to 24 age group saying they are most likely to trust their vet's advice over their doctor's.
Nationally, nearly four out of ten pet owners put more faith in vets than doctors, rising to 7 in 10 in some parts of the country.
Talking of which, my mother needs a new hip. Any of you up for it?
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
The RCVS has announced that nominations are now open for the Veterinary Nursing Golden Jubilee Award 2014, an an honour which recognises those who have made an outstanding contribution to the veterinary nursing profession.
Nominations can be made until 1 May 2014 and this year the College is looking for nominees who have made an exceptional contribution to the profession, animal welfare or patient care - whether in clinical practice, education, research or politics. Nominees can be registered or listed veterinary nurses, veterinary surgeons or lay people.
Kathy Kissick, Chair of VN Council, said: "With this award we are looking for someone who can be an excellent ambassador for the veterinary nursing profession; who has made a real and substantial difference to the profession; and who can raise its profile and fight its corner.
"I would urge all those who are passionate about the profession and its future to put forward someone who they think is deserving of this honour."
The award was launched in 2011 to celebrate the 50th anniversary of the first RCVS veterinary nursing training scheme. The first recipient of the award was Jean Turner, while Sue Badger received the accolade in 2012.
The nomination form for the award can be downloaded from www.rcvs.org.uk/goldenjubilee which also features a video of Kathy Kissick talking about its importance. Alternatively, you can view the video on www.youtube.com/rcvsvideos
The nominators must be registered/listed veterinary nurses or veterinary surgeons but the two additional proposers can be lay people.
For further information about the award please contact Annette Amato, Deputy Head of Veterinary Nursing, on 020 7202 0713 or a.amato@rcvs.org.uk.
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
The leaflets are designed to be used as part of the veterinary consultation and provide information to help owners understand what is involved in the examination, including the reasons for the procedure, the preparation required, any associated risks, and what happens during and after the examination.
They are available in a PDF format which can be printed and stamped with the veterinary practice details or emailed to clients.
Philip Lhermette, Principal of Elands Veterinary Clinic, specialist in minimally invasive surgery and Past President of the BSAVA said: “Minimally invasive surgery is becoming commonplace in general veterinary practice and is much sought after by clients, especially for routine procedures such as bitch spays.
"It is important that clients are properly informed of all the risks and benefits of a minimally invasive procedure and these leaflets provide the first opinion practitioner with an ideal means of providing such information in a succinct and easily understood format."
The new leaflets are available via the BSAVA Library here: https://www.bsavalibrary.com/content/cilgroupprocedures.
Access to the entire range of client information leaflets (including canine and feline behaviour, exotic pets, and medicines) is available for an annual subscription of £40.
BSAVA members have access to these leaflets as part of their membership benefits.
If you have any suggestions for further client information leaflets, email: publications@bsava.com.
There are 10 candidates standing this year and vets can vote for up to three of them until 5pm on Friday 21st April 2023:
The biographies and statements for each candidate are available at www.rcvs.org.uk/vetvote23 where each candidate has also answered two questions of their choice submitted by members of the profession.
The three candidates who receive the most votes will take up their four-year terms on RCVS Council at the RCVS Annual General Meeting on Friday 7th July 2023.
Any veterinary surgeons who have not received their voting email should contact CES directly on support@cesvotes.com stating which election they intend to vote in.
Intervet/Schering-Plough has launched Vectin chewable tablets, an ivermectin wormer for horses which is administered as a treat straight from the hand rather than in the traditional paste or granule formulation.
According to the company, syringe handling, horse acceptance and the tendency to spit out some or all of the paste are common problems reported by owners when worming their horses, and more than 55% admit that these issues can result in a mixture of emotions, including frustration, anxiety and upset.
Field studies with Vectin showed more than 70% spontaneous acceptance by horses and the simple calculation of one tablet for every 110kg of a horse or foal's bodyweight helps to reduce wastage as unused tablets can be stored away for future use.
Pharmacokinetics studies have demonstrated improved bioavailability (AUC) and maximal concentration (Cmax) when compared with an equivalent competitor ivermectin paste formulation. Trials have also shown that a more consistent blood concentration of ivermectin when given as a chew which could potentially limit the chance of inducing resistance.
Intervet/Schering Plough says that used as part of a strategic worming plan, Vectin chewable tablets control potentially a wide range of endoparasites including small and large strongyles, stomach worms, cutaneous worms and stomach bots.
Vectin chewable tablets are available as a seven-tablet blister pack, perfect for treating a horse or a couple of ponies. For yards, a tub of 60 tablets is available, containing enough to dispense product for worming approximately 12 horses.
Vectin chewable tablets are recommended for use alongside Pyratape P and Panacur in Intervet/Schering-Plough Animal Health's Active3 worming plan, a strategic three-year approach to rotating wormers in order to minimize the risk of resistance developing. Visit http://www.intervet.co.uk/ for a copy of the three-year plan.
In contrast to the British Veterinary Association, The National Office of Animal Health (NOAH) has welcomed the decision by DEFRA not to proceed with the proposal contained in the draft Veterinary Medicines Regulations 2010 to prohibit the advertising of antimicrobials to farmers.
NOAH says it believes the proposal would have had a negative effect on farmers' ability to maintain their knowledge and awareness of animal health and welfare issues, and did not believe that it would reduce antimicrobial resistance profiles.
NOAH chief executive Phil Sketchley said: "Farmers, as professional producers of food, need to be kept well briefed on the antimicrobials they use, following prescription by their veterinary surgeons. Promotion by our members plays a key role in this and in educating farmers about animal welfare and disease."
NOAH members follow rigid rules on advertising and promotion through the longstanding Code of Practice for the Promotion of Animal Medicines.
Phil added: "The NOAH Code already goes beyond the Veterinary Medicines Regulations and is reviewed each year - this year we will be particularly looking to ensure that it fully reflects the industry's commitment to disease education and information on responsible use, particularly in relation to antimicrobial promotion. We have planned, at our Code review meeting in February, further discussions within NOAH and with the VMD to finalise how this can best be achieved.
"Importantly we must always remember that antimicrobial medicines for all animals are POM-V, meaning they have to be prescribed by a veterinary surgeon, and therefore it should be the vet who makes the decision on whether an antibiotic is needed. If such therapy is indicated, the most appropriate antibiotic for an animal or group of animals is selected by the veterinary surgeon based on the clinical signs shown, the current disease situation on the farm and in the area and where appropriate and feasible, is based on bacterial culture and sensitivity testing."
Using promotion to encourage responsible use, NOAH launched its 'Use Medicines Responsibly' campaign in 2009. A recommendation was made that members include a strap line on promotional material advising users to 'use medicines responsibly'.
NOAH was a founder member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and continues to be a strong contributor to and supporter of RUMA's communications to farmers including the antimicrobial guidelines. These guidelines are not intended to influence the veterinary surgeon's decision to prescribe but help support ways that the veterinary surgeon and farmer can work together to reduce the need to prescribe antimicrobials whilst ensuring they are used responsibly once prescribed in line with the principle of 'as little as possible but as much as necessary'.
Phil said: "Antibiotics are essential for the health and welfare of the UK's livestock population. NOAH accepts that antimicrobial resistance is a serious and growing subject of discussion for the medical and veterinary professions and we need to continue to take this matter seriously."
Life Technologies Animal Health has announced the launch of a new qPCR test to improve the diagnosis of mastitis and respiratory disease caused by Mycoplasma bovis.
According to the company, the TaqVet Mycoplasma Bovis (M. bovis) polymerase chain reaction (PCR) kit is based on a new target gene in the M. bovis genome and thus can distinguish better between infections caused by M. bovis and M. agalactiae - so there is less risk of false positive results and improved sensitivity and specificity.
The test is based on real-time PCR technology, and delivers results in two and a half hours.
Eric Sellal, Head of Animal Health EMEA at Life Technologies said: "The improved sensitivity of this new test means that veterinarians will be able to monitor dairy herds for sub-clinical infection using samples from the bulk tank. And of course it can also be used to diagnose mycoplasma infection in individual cases of clinical mastitis and respiratory disease."
Life Technologies says the test system incorporates a number of other improvements which simplify and speed up processing in the laboratory, including automatic extraction using magnetic bead technology.
It is estimated that bovine pneumonia costs the European industry around 500million Euros each year, with 30% accounted for by M. bovis. Other diseases associated with the organism include mastitis and arthritis.
Mycoplasma is slow and difficult to culture in the laboratory and current antibiotic treatment is not very cost-effective. Therefore, prevention is a cornerstone of M. bovis management.
The TaqVet Mycoplasma Bovis PCR kit will be made available in other EU countries and via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.